Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis

    • Coronavirus disease (COVID-19)

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Scientific Resources
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy
OUR PURPOSE/ Meeting the Global Challenges of Metastatic Breast Cancer
December 16, 2016

When it comes to caring for patients with metastatic (stage IV) breast cancer, or breast cancer that has spread to other parts of the body, many have needs that extend well beyond the hospital treatment room. The Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge (SPARC), an initiative launched by the Union for International Cancer Control (UICC) in partnership with Pfizer Oncology, has awarded grants to 20 organizations in 18 countries around the globe who are addressing unmet needs for this patient community. Read on to learn more about how some of the grant recipients are working to make a difference in the lives of metastatic breast cancer patients around the world.

A Support Group for Rural Women with Breast Cancer

In 2012, Rwanda’s Butaro Cancer Center for Excellence (BCCOE) became a model across East Africa for being the first cancer treatment center to open in a rural region. Four years prior, the area did not even have a hospital. In the time since its opening, BCCOE has enrolled some 5,000 patients, offering advanced treatment and diagnostic services such as chemotherapy, surgery, and pathology.

As BCCOE continued to grow, its leadership identified a critical missing piece. Many of its patients, rural women with metastatic breast cancer, could benefit from a peer support group to help cope with the mental, emotional, and socioeconomic challenges of the disease.

“Often some of the best sources of support for patients are those that have ‘walked the walk’ and gone through similar challenges,” said Jeff Marvin, Media Relations Manager for Partners In Health, a global nonprofit, which in partnership with the Rwandan Ministry of Health established the hospital. “Having peer-to-peer support is important with any chronic disease because these patients are vulnerable to anxiety and depression. Support needs to be multifaceted and beyond the hospital walls.”

In April, after receiving a SPARC grant, BCCOE was able to launch its first support group for 15 rural women with breast cancer, many of whom are battling metastatic disease. An unfortunate reality in the developing world is that breast cancer often is diagnosed six times later than in advanced countries that offer widespread access to routine mammograms.1

Across all cultures, an initial challenge to set up an effective support group is training staff or “navigators” to lead the sessions. In BCCOE’s case, its medical staff and social workers often hail from other regions or socioeconomic classes and needed training in facilitating a group for the rural patient population in need.

A key component of the support group’s success was developing a curriculum to train the navigators to build an environment of confidentiality and trust so group participants could open up to express their challenges and feelings. The nuanced, unique curriculum has helped nurses and social workers communicate in a way that allows participants to share their experiences.

Another key component has been educating local patients about breast cancer and its treatment. Prior to the opening of the BCCOE, many people in the region had little awareness of breast cancer and, if they understood that they had the disease, they had no accessible options for treatment. Helping patients understand what the disease is and where it comes from—that it’s not related to infection, and that it’s treatable—has been a critical part of that education.

Across central East Africa, Rwanda has become a “poster child” for rapid health care development. As the burden of communicable diseases such as HIV and tuberculosis are successfully addressed, the next frontier is to combat non-communicable disease such as cardiovascular disease, diabetes, and cancer. Cancer, in particular, presents the greatest challenge because it requires a sophisticated medical infrastructure at the community level. Yet full clinical care at every level is critical for patients’ health and quality of life.

Creating an Online Community for Metastatic Patients in Mexico

In recent years, breast cancer rates have been rising in Mexico,2 and the public health community is scrambling to address and treat the disease.3 Since 2002, the nonprofit Cim*ab Foundation, founded by two breast cancer survivors, has been working throughout Mexico to raise awareness of the disease and support patients and their families. With the help of a SPARC grant, the foundation recently launched an online resource and community for people with metastatic breast cancer in Mexico and other Spanish-speaking countries. “We saw these patients have been neglected for so long. No one talks about it,” said Bertha Aguilar, who co-founded the foundation with Alejandra de Cima.

The online site TantoPorHacer.org (“So Much to Do”) includes community forums, online lectures with experts, and emotional support for metastatic patients and their families. “We created a website so they can have their own voice, for them to have more access to quality treatments, and talk with experts. We want to help give them a better quality of life and get their needs met.”

Training Nurses to Educate Metastatic Breast Cancer Patients

In Bulgaria, the Association of Cancer Patients(APOZ), has worked for the past 11 years to improve treatment access and education for breast cancer patients. Thanks to a SPARC grant, the organization has recently launched the ABC Patient Academy to train nurses and oncologists to better educate metastatic breast cancer patients about their disease and their role in managing it. “There’s a lack of time on the part of the medical profession to explain and involve patients in the treatment process. And more so for metastatic breast cancer patients where the situation is much graver,” said Teodora Kolarova of APOZ.

Launched in 10 oncology hospitals in Bulgaria’s capital city Sofia, the program is training nurses to work with metastatic patients from day one of their treatment journey. “We want to bridge the gap in communication and understanding of the disease,” said Kolarova. In the future, they hope this pilot program will become the standard of care for all breast cancer patients in Bulgaria.

As the program continues, APOZ founders have seen how investing in the emotional needs of metastatic breast cancer patients can have an overall impact on their wellbeing and adherence to treatment. “More and more of our patients feel like they matter because of receiving personalized care without having to feel vulnerable,” said Evgenyia Aleksandrova, the founder of APOZ.4

1Faster, Better Care for Breast Cancer in Rwanda. Partners in Health. Available at http://www.pih.org/blog/faster-better-care-for-breast-cancer-in-rwanda. Accessed on November 22, 2016.
2Breast cancer in Mexico: a growing challenge to health and the health system. Available at https://www.ncbi.nlm.nih.gov/pubmed/22846838. Accessed on November 22, 2016.
3Cancer: Mexico’s Growing Problem. Available at http://globalhealthsciences.ucsf.edu.s116768.gridserver.com/news-events/cancer-mexico-s-growing-problem. Accessed on November 22, 2016.
4SPARC grant awardees – Meet Evgenyia from Bulgaria. Available at http://www.uicc.org/sparc-grant-awardees-–-meet-evgenyia-bulgaria. Accessed on November 22, 2016.
Related Hot Topics
Media Name: Trachoma-Tile_300x170.jpg
Traveling Nine Thousand Miles to Help End Trachoma
Media Name: shutterstock_227114035_300x170.jpg
Día de la Mujer Latina: Promoting Healthy Behaviors
Media Name: GHFdeploymentHERO_300x170.jpg
15 Years of Global Health Fellows: Lasting Impact in Local Communities
Media Name: Blueprint-Animation-Hero-300x170.jpg
How to Rid the World of Neglected Tropical Diseases
Media Name: improving_womens_health_1000x450.jpg
Improving Women’s Health through Family Planning Services
Media Name: DrKnirsch_heroimage__1000x450.jpg
A Family Legacy: Improving Global Public Health
Media Name: MORDOR_TileImage_300x170.jpg
An Intervention That Can Significantly Improve Child Health
Media Name: Pfizer_Feature_300x170.jpg
Pfizer 2017 Annual Review: The Power of Science
Tags
Corporate Responsibility
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.